ReviewJAK-STAT2013

JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasms.

Karoline Gäbler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.